RIM
GILD icon

Rockbridge Investment Management’s Gilead Sciences GILD Stock Holding History

Rockbridge Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,000
Closed -$59.7K – 707
2022
Q1 		$59.7K Hold
1,000
– – 0.01% 272
2021
Q4 		$73K Buy
+1,000
New +$68.9K 0.01% 293
2021
Q1 		– Sell
-535
Closed -$31K – 730
2020
Q4 		$31K Buy
535
+376
+236% +$22.7K 0.01% 346
2020
Q3 		$10K Hold
159
– – ﹤0.01% 464
2020
Q2 		$12K Buy
+159
New +$12.2K ﹤0.01% 405

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rockbridge Investment Management's GILD Position: Q2 2022 in Review

Rockbridge Investment Management sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 1,000 shares — an estimated $59.7K sold.

Rockbridge Investment Management first reported a position in GILD in Q2 2020 and held it in 5 quarters. The position peaked at $73K in Q4 2021. 1,604 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

  • Rockbridge Investment Management reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
  • Rockbridge Investment Management sold 1,000 Gilead Sciences shares in Q2 2022, an estimated $59.7K.
  • Rockbridge Investment Management first reported a position in Gilead Sciences in Q2 2020 and held it in 5 quarters.
  • Rockbridge Investment Management's Gilead Sciences position peaked at $73K in Q4 2021.
  • 1,604 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on Rockbridge Investment Management's 13F filing for Q2 2022, filed 28 May 2024.